PCVX
PCVX
US92243G1085
Vaxcyte, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
923.675.000 569.546.000
62.2%
Operating Income -923.675.000 -569.546.000
62.2%
Pretax Income -766.628.000 -463.927.000
65.2%
Net Income Common Stockholders -766.628.000 -463.927.000
65.2%
-- --
--
-- --
--
ende